Silo Pharma, Inc. current report, 14 July 2016

SEC Filing Summary: Point Capital, Inc. (Form 8-K)

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Point Capital, Inc. on July 14, 2016. The filing discloses a change in the company's principal independent accountants. The registrant is incorporated in Delaware and maintains its principal executive offices in Englewood, New Jersey.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding accounting services and does not contain financial performance data.

Material Changes

On July 14, 2016, Point Capital, Inc. retained Friedman LLP as its new principal independent accountants. This decision was approved by the Registrant's Audit Committee. The filing confirms that prior to this date:

  • The Registrant did not consult Friedman regarding the application of accounting principles to specified transactions or the type of audit opinion that might be rendered.
  • No written report or oral advice was provided by Friedman that was considered an important factor in reaching a decision on accounting, auditing, or financial reporting issues.
  • The Registrant did not consult Friedman regarding any "disagreements" or reportable events as defined in Item 304(a)(1)(iv) and (v) of Regulation S-K.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of the accountant change. No unusual items were reported.

Investor Verification Checklist

  • Verify the identity and credentials of the new auditor, Friedman LLP.
  • Confirm the date of the previous auditor's departure and the reason for the change (not explicitly detailed beyond the retention of the new firm).
  • Review subsequent filings (e.g., 10-K or 10-Q) to assess the impact of the auditor change on financial reporting quality.
  • Check for any pending litigation or regulatory inquiries related to the prior accounting firm.